Litcius/Paper detail

MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance

Jordy C.G. van der Zwet, Jessica G. C. A. M. Buijs-Gladdines, Valentina Cordo’, Donna O. Debets, Willem K. Smits, Zhongli Chen, Jelle Dylus, Guido J.R. Zaman, Maarten Altelaar, Koichi Oshima, Beat Bornhäuser, Jean‐Pierre Bourquin, Jan Cools, Adolfo A. Ferrando, Josef Vormoor, Rob Pieters, Britta Vormoor, Jules P.P. Meijerink

2021Leukemia48 citationsDOI

Topics & Concepts

MAPK/ERK pathwayCancer researchMEK inhibitorInterleukin-7 receptorSelumetinibPhosphorylationSignal transductionBiologyInternal medicineEndocrinologyMedicineCell biologyImmunologyT cellIL-2 receptorImmune systemAcute Lymphoblastic Leukemia researchCell death mechanisms and regulationCAR-T cell therapy research
MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance | Litcius